Clinical trial

An Observational Post Authorisation Study to Evaluate Safety and Efficacy in Patients Receiving Azacitidine in Daily Clinical Practice in the Netherlands

NCT02891551

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2012-05-01

PhaseN/A

Study timeline

Study start (actual)2012-05-01Date precision: day

Registry last updated2019-07-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Myelodysplastic Syndromesunresolved

Leukemia, Myelomonocytic, Chronicunresolved

Leukemia, Myeloid, Acuteunresolved

Interventions

Sponsors & collaborators

Celgenelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02891551 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.